Evidence map›Paper›PMID 41827819›Full record

ArticleCancers2026

Correction: Grant et al. Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma.

Michael Grant, Barbara Cipriani, Alastair Corbin, David Miller, Alan Naylor, Stuart Hughes, Tom McCarthy, Sumeet Ambarkhane, Danish Memon, Michael Millward and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Michael GrantSt Bartholomew's Hospital, London EC1A 7BE, UK.
Barbara CiprianiPathios Therapeutics Limited, Oxford OX2 6HJ, UK.ORCID 0000-0002-6492-3141
Alastair CorbinPathios Therapeutics Limited, Oxford OX2 6HJ, UK.
David MillerPathios Therapeutics Limited, Oxford OX2 6HJ, UK.ORCID 0000-0001-9656-3024
Alan NaylorPathios Therapeutics Limited, Oxford OX2 6HJ, UK.
Stuart HughesPathios Therapeutics Limited, Oxford OX2 6HJ, UK.
Tom McCarthyPathios Therapeutics Limited, Oxford OX2 6HJ, UK.
Sumeet AmbarkhanePathios Therapeutics Limited, Oxford OX2 6HJ, UK.
Danish MemonMolecule to Medicine, Oxford OX1 4PS, UK.ORCID 0000-0002-3510-0170
Michael MillwardSchool of Medicine, University of Western Australia and Linear Clinical Research, Perth, WA 6009, Australia.
Sumanta PalCity of Hope Comprehensive Cancer Center, City of Hope, Duarte, CA 91010, USA.
Ignacio MeleroDepartment of Immunology and Immunotherapy, Clinica Universidad de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-1360-348X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41827819
PMCPMC12985320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.